Carrel Aline, Yiannakas Adonis, Roukens Jaap-Jan, Reynoso-Moreno Ines, Orsi Markus, Thakkar Amol, Arus-Pous Josep, Pellegata Daniele, Gertsch Jürg, Reymond Jean-Louis
Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, Bern 3012, Switzerland.
Institute of Biochemistry and Molecular Medicine, University of Bern, Gertrud-Woker Strasse 5, Bern 3012, Switzerland.
J Med Chem. 2025 May 8;68(9):9176-9201. doi: 10.1021/acs.jmedchem.4c02549. Epub 2025 Apr 24.
To assess how much structural diversity remains unexploited in simple drug scaffolds, we investigated ring systems functionalized with amine handles. Starting from the ring systems database GDB-4c, we enumerated 1139 possible amines and diamines with up to two five-, six-, or seven-membered rings. From the 680 cases not listed in PubChem, we synthesized several unprecedented - and -fused azepanes and tested possible targets predicted using the polypharmacology browser PPB2. From this screening campaign, an -benzylated azepane emerged as a potent inhibitor of monoamine transporters with some selectivity toward norepinephrine (NET, SLC6A2) and dopamine transporter (DAT, SLC6A3) inhibition (IC < 100 nM) in combination with σ-1R inhibition (IC ≈ 110 nM). The profile, favorable pharmacokinetic properties, and preliminary behavioral and metabolomic effects in mice suggest a potential of -benzylated bicyclic azepanes to target neuropsychiatric disorders. These experiments highlight the potential of simple but still unexplored scaffolds for drug discovery.
为了评估在简单药物骨架中仍有多少结构多样性未被开发利用,我们研究了用胺基修饰的环系。从环系数据库GDB - 4c开始,我们列举了1139种可能的胺和二胺,它们最多含有两个五元、六元或七元环。从PubChem中未列出的680个案例中,我们合成了几种前所未有的稠合氮杂环庚烷,并测试了使用多药理学浏览器PPB2预测的可能靶点。通过这次筛选,一种苄基化氮杂环庚烷作为单胺转运体的有效抑制剂出现,对去甲肾上腺素转运体(NET,SLC6A2)和多巴胺转运体(DAT,SLC6A3)具有一定的抑制选择性(IC < 100 nM),同时还具有σ-1R抑制作用(IC ≈ 110 nM)。其特性、良好的药代动力学性质以及在小鼠中的初步行为和代谢组学效应表明,苄基化双环氮杂环庚烷具有针对神经精神疾病的潜力。这些实验突出了简单但仍未被探索的骨架在药物发现中的潜力。